| 1 |
34996912 | High BRCA1 gene expression increases the risk of early distant metastasis in ER+ breast cancers. | 2022 Jan 7 |
1 |
| 2 |
33006205 | Finding the five-year window: A qualitative study examining young women's decision-making and experience of using tamoxifen to reduce BRCA1/2 breast cancer risk. | 2021 Feb |
2 |
| 3 |
33215232 | Association between BRCA mutations and endometrial carcinoma: a systematic review with meta-analysis. | 2021 Jun |
1 |
| 4 |
32929377 | The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer. | 2020 |
1 |
| 5 |
30537139 | Tamoxifen therapy benefit predictive signature combining with prognostic signature in surgical-only ER-positive breast cancer. | 2019 Jul |
3 |
| 6 |
30664189 | Arsenic‑induced BRCA1 CpG promoter methylation is associated with the downregulation of ERα and resistance to tamoxifen in MCF7 breast cancer cells and mouse mammary tumor xenografts. | 2019 Mar |
1 |
| 7 |
30872561 | Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know. | 2019 |
1 |
| 8 |
30937657 | 4-Hydroxytamoxifen enhances sensitivity of estrogen receptor α-positive breast cancer to docetaxel in an estrogen and ZNF423 SNP-dependent fashion. | 2019 Jun |
1 |
| 9 |
31184616 | [BRCA1 and Estrogen Receptor α Expression Regulation in Breast Cancer Cells]. | 2019 May-Jun |
1 |
| 10 |
29686231 | Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1. | 2018 Apr 23 |
5 |
| 11 |
29928444 | Expression signature of ten genes predicts the survival of patients with estrogen receptor positive-breast cancer that were treated with tamoxifen. | 2018 Jul |
1 |
| 12 |
28968398 | SNPs near the cysteine proteinase cathepsin O gene (CTSO) determine tamoxifen sensitivity in ERα-positive breast cancer through regulation of BRCA1. | 2017 Oct |
3 |
| 13 |
25502281 | Clinical management of women at high risk of breast cancer. | 2015 Feb |
1 |
| 14 |
25838159 | Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study. | 2015 Sep |
1 |
| 15 |
26022977 | Tamoxifen and risk of contralateral breast cancer among women with inherited mutations in BRCA1 and BRCA2: a meta-analysis. | 2015 Jul |
4 |
| 16 |
26575173 | A new class of small molecule estrogen receptor-alpha antagonists that overcome anti-estrogen resistance. | 2015 Dec 1 |
5 |
| 17 |
23859469 | Health care provider recommendations for reducing cancer risks among women with a BRCA1 or BRCA2 mutation. | 2014 Jan |
1 |
| 18 |
24567198 | Surgical management of breast cancer in BRCA-mutation carriers: a systematic review and meta-analysis. | 2014 Apr |
1 |
| 19 |
24594998 | Uptake of tamoxifen in consecutive premenopausal women under surveillance in a high-risk breast cancer clinic. | 2014 Apr 2 |
1 |
| 20 |
24838932 | Genetics of endometrial cancer. | 2014 Sep |
1 |
| 21 |
24909173 | IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer. | 2014 Jun 9 |
2 |
| 22 |
24951267 | Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. | 2014 Jul |
2 |
| 23 |
23562522 | The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. | 2013 Jul |
1 |
| 24 |
23918944 | Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. | 2013 Sep 1 |
3 |
| 25 |
23980083 | Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation. | 2013 Nov 1 |
1 |
| 26 |
22706629 | BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients. | 2012 Aug |
2 |
| 27 |
21425892 | Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families. | 2011 Apr |
5 |
| 28 |
20135344 | Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer. | 2010 Sep |
1 |
| 29 |
20921464 | Compliance with tamoxifen in women with breast cancer and a BRCA1 or BRCA2 mutation. | 2010 Nov 20 |
1 |
| 30 |
18997820 | Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor-coregulator interactions. | 2009 Jan 29 |
7 |
| 31 |
19223511 | The complex relationship between BRCA1 and ERalpha in hereditary breast cancer. | 2009 Mar 1 |
1 |
| 32 |
19577280 | Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers. | 2009 Oct |
2 |
| 33 |
18196574 | International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. | 2008 May 1 |
1 |
| 34 |
18405391 | Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers. | 2008 Apr 13 |
2 |
| 35 |
16962648 | The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study. | 2007 Jan |
2 |
| 36 |
17234721 | Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice. | 2007 Jun |
3 |
| 37 |
17250664 | A survey of preventive measures among BRCA1 mutation carriers from Poland. | 2007 Feb |
1 |
| 38 |
17471565 | Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers: a systematic review. | 2007 Jul 15 |
1 |
| 39 |
16331614 | Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. | 2006 May 1 |
2 |
| 40 |
15750629 | Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer. | 2005 May 19 |
1 |
| 41 |
15925821 | Time to reconsider subcutaneous mastectomy for breast-cancer prevention? | 2005 Jun |
1 |
| 42 |
15951959 | The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation. | 2005 |
1 |
| 43 |
16155942 | Is BRCA1/BRCA2-related breast carcinogenesis estrogen dependent? | 2005 Oct 15 |
1 |
| 44 |
14694444 | Antisense blocking of BRCA1 enhances sensitivity to plumbagin but not tamoxifen in BG-1 ovarian cancer cells. | 2004 Jan |
1 |
| 45 |
15197194 | Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. | 2004 Jun 15 |
1 |
| 46 |
15280184 | Reducing breast cancer incidence in familial breast cancer: overlooking the present panorama. | 2004 |
2 |
| 47 |
15382059 | Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. | 2004 Nov 10 |
1 |
| 48 |
20233484 | The prevention of hereditary breast and ovarian cancer: a personal view. | 2004 Feb 15 |
1 |
| 49 |
12697859 | Re: Tamoxifen may be an effective treatment for BRCA1-related breast cancer irrespective of estrogen receptor status. | 2003 Apr 16 |
1 |
| 50 |
14645421 | Tamoxifen as chemoprevention in BRCA1 and BRCA2 mutation carriers with breast cancer: a pilot survey of physicians. | 2003 Dec 1 |
2 |